| Date Filed | Type | Description |
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2023 |
4
| HOMCY CHARLES J (Director) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Paid exercise price by delivering 1,300 shares
@ $14.09, valued at
$18.3k
Exercised 3,759 restricted stock units
@ $0 |
|
| 02/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2022 |
4
| HOMCY CHARLES J (Director) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Paid exercise price by delivering 1,301 shares
@ $9.64, valued at
$12.5k
Exercised 3,760 restricted stock units
@ $0 |
|
| 08/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2022 |
4
| HOMCY CHARLES J (Director) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Paid exercise price by delivering 1,541 shares
@ $6.74, valued at
$10.4k
Exercised 3,759 restricted stock units
@ $0 |
|
| 03/15/2022 |
4
| HOMCY CHARLES J (Director) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Granted 30,078 restricted stock units
@ $0 |
|
| 12/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2021 |
4
| HOMCY CHARLES J (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 13,286 options to buy
@ $28.2, valued at
$374.7k
|
|
| 06/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/26/2021 |
4
| HOMCY CHARLES J (Director) has filed a Form 4 on Population Health Investment Co., Inc.|
Txns:
| Acquired 43,125 options to buy
@ $250, valued at
$10.8M
|
|
| 11/17/2020 |
3
| HOMCY CHARLES J (Director) has filed a Form 3 on Population Health Investment Co., Inc. |
| 10/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/29/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2020 |
4
| HOMCY CHARLES J (Chairman of Pharmaceuticals) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Granted 112,422 options to buy
@ $29, valued at
$3.3M
|
|
| 06/02/2020 |
3
| HOMCY CHARLES J (Director) has filed a Form 3 on PLIANT THERAPEUTICS, INC. |
| 04/07/2020 |
4
| HOMCY CHARLES J (Chairman of Pharmaceuticals) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Gifted 40,000 shares
@ $0 |
|
| 02/12/2020 |
4
| HOMCY CHARLES J (Chairman of Pharmaceuticals) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Sold 20,000 shares
@ $36, valued at
$720k
|
|
| 01/16/2020 |
4
| HOMCY CHARLES J (Chairman of Pharmaceuticals) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Sold 10,000 shares
@ $35, valued at
$350k
Exercised 10,000 options to buy
@ $17, valued at
$170k
|
|
| 12/16/2019 |
4
| HOMCY CHARLES J (Chairman of Pharmaceuticals) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Granted 82,878 options to buy
@ $37.45, valued at
$3.1M
|
|
| 07/03/2019 |
4
| HOMCY CHARLES J (Chairman of Pharmaceuticals) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Exercised 47,165 units
@ $0
Exercised 132,317 units
@ $0
Exercised 66,729 options to buy
@ $0
Exercised 406,723 options to buy
@ $0
Exercised 418,016 options to buy
@ $0
Exercised 290,476 options to buy
@ $0 |
|
| 06/27/2019 |
3
| HOMCY CHARLES J (Chairman of Pharmaceuticals) has filed a Form 3 on BridgeBio Pharma, Inc. |
| 04/01/2019 |
4
| HOMCY CHARLES J (Former Director) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC|
Txns:
| Granted 10,000 options to buy
@ $33.59, valued at
$335.9k
|
|
| 01/04/2019 |
4
| HOMCY CHARLES J (Director) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC|
Txns:
| Exercised 45,923 shares
@ $5.1, valued at
$234.2k
Exercised 19,607 options to buy
@ $5.1, valued at
$100k
Exercised 14,835 options to buy
@ $5.1, valued at
$75.7k
Exercised 11,481 options to buy
@ $5.1, valued at
$58.6k
|
|
| 12/19/2018 |
4
| HOMCY CHARLES J (Director) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC|
Txns:
| Sold 63,518 shares
@ $18.602, valued at
$1.2M
Sold 700 shares
@ $19.2, valued at
$13.4k
Exercised 25,782 shares
@ $4.1, valued at
$105.7k
Exercised 24,390 options to buy
@ $4.1, valued at
$100k
Exercised 39,828 options to buy
@ $4.1, valued at
$163.3k
Exercised 25,782 options to buy
@ $4.1, valued at
$105.7k
|
|
| 11/16/2018 |
4
| HOMCY CHARLES J (Director) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC|
Txns:
| Exercised 93,698 shares
@ $4.1, valued at
$384.2k
Exercised 93,698 options to buy
@ $4.1, valued at
$384.2k
|
|
| 06/22/2018 |
4
| HOMCY CHARLES J (Director) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Granted 15,000 options to buy
@ $42.25, valued at
$633.8k
|
|
| 06/08/2018 |
4
| HOMCY CHARLES J (Director) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC|
Txns:
| Granted 3,000 shares
@ $0
Granted 6,000 options to buy
@ $42.81, valued at
$256.9k
|
|
| 02/14/2018 |
5
| HOMCY CHARLES J (Director) has filed a Form 5 on Global Blood Therapeutics, Inc. |
| 02/14/2018 |
5/A
| HOMCY CHARLES J (Director) has filed a Form 5/A on Global Blood Therapeutics, Inc. |
| 10/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|